GeneAI Forecast is built on a foundation of DNA data and key biomarkers, forming a personalized health and wellness baseline for each individual. From this foundation, artificial intelligence ...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...
The DNA synthesis market offers significant growth opportunities driven by tailored therapies, DNA-based research, and diagnostics. Key market prospects include advancements in enzymatic synthesis, ...
The future of medicine is being quietly built in an unassuming Perth lab by an impressive group that is flying under the ...
Integrated DNA Technologies expands Coralville manufacturing footprint to support global demand for minimal residual disease solutions: Coralville, Iowa Wednesday, April 22, 2026, ...
Roche is handing over $595 million to bolster its Foundation Medicine business with a deal to snap up SAGA Diagnostics. | ...
Dr. Martin explains the role of biological age, NAD levels, and advanced diagnostics in guiding long-term health strategies.
Defense attorneys have called family members to talk about Horner’s childhood, and witnesses who testified about autism and ...
Beyond traditional monitoring of kidney transplant recipients, donor derived-cell free DNA may permit early identification of graft damage.
Health and Me on MSN
World DNA Day: Are Indians more prone to early onset of lifestyle diseases?
This DNA Day, let us understand that genetics is not destiny, but it does set the stage.
Diagnostic Laboratory today announced the launch of long-read genomic sequencing, marking a significant advancement in ...
The MarketWatch News Department was not involved in the creation of this content.-- Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results